美国的一项研究发现,Galleri血液测试将癌症检测率提高到7倍以上,查明了许多早期癌症,包括没有现期筛查选择的癌症。 A U.S. study found the Galleri blood test boosted cancer detection over sevenfold, identifying many cancers early, including those without current screening options.

美国的一项大型研究发现,在标准癌症筛查中加上加列里血检,将癌症检测率提高到7倍以上,在早期发现一半以上的癌症,在没有现有筛查办法的情况下发现许多类型的癌症。 A large U.S. study found that adding the Galleri blood test to standard cancer screenings boosted cancer detection over sevenfold, identifying more than half of cancers at early stages and detecting many types without current screening options. 该试验分析血液中的DNA碎片以发现癌症信号,在检测和排除癌症时显示出很高的准确性。 The test, which analyzes DNA fragments in blood to spot cancer signals, showed high accuracy in both detecting cancer and ruling it out. 在ESMO 2025大会上,GRAIL PATHFINDER 2试验的结果,涉及超过23,000名成年人,并进行了介绍. Results from the GRAIL PATHFINDER 2 trial, involving over 23,000 adults, were presented at the ESMO Congress 2025. 研究人员说,该测试可大大改进早期发现和结果,特别是难以检测的癌症的早期发现和结果,尽管在广泛使用之前还需要进一步研究。 Researchers say the test could significantly improve early detection and outcomes, especially for hard-to-detect cancers, though further study is needed before widespread use.